Institutional investors purchased a net $1.4 million shares of AVEO during the quarter ended June 2015 and now own 28.79% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CORMORANT ASSET MANAGEMENT LLC Bought 1.6 Million shares of Aveo Pharmaceuticals Inc